Two Sigma Advisers »

4d Molecular Therapeutics In shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.8M 550k 8.69
2025-06-30 $2.8M 743k 3.71
2025-03-31 $1.6M 490k 3.23
2024-12-31 $704k 126k 5.57
2024-09-30 $248k 23k 10.81
2023-09-30 $1.1M 87k 12.73
2023-06-30 $2.0M 112k 18.07
2023-03-31 $1.7M 100k 17.19
2022-12-31 $491k 22k 22.21